Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Clinical trial NCT00157079 · COMPLETED

Trial details

NCT number: NCT00157079
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome

Start date: 2002-06-25
Primary completion: 2003-12-16
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.